Collegium Pharmaceutical, Inc.
COLL
Health Care
2
exclusion reasons
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Collegium Pharmaceutical, Inc. develops and markets abuse-deterrent opioid pain medications, a process that requires extensive animal testing for regulatory approval. The company’s product pipeline and marketed drugs, including its abuse-deterrent formulations, are subject to mandatory non-clinical safety and efficacy studies that involve laboratory animals. This testing is a standard, required component of pharmaceutical development for opioid analgesics, placing the company within the category of businesses whose commercial operations rely on animal experimentation.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for pain management, including its abuse-deterrent extended-release oxycodone product, Xtampza ER. The company's business model inherently requires animal testing as part of the drug development and regulatory approval process. In its public SEC filings, Collegium explicitly cites the "completion of preclinical laboratory and animal testing" as a standard and necessary step in its development programs, conducted in compliance with FDA good laboratory practice (GLP) regulations. This reliance on animal models is a foundational component of bringing its pharmaceutical products to market.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.